Acino International AG
AddressAcino International AG
Acino specializes in the development, registration and manufacture of generic and innovative pharmaceuticals with sophisticated Formulation technologies for which Acino also has its own patents.
With focus on solid oral dosage forms with modified Drug release, therapeutic systems for transdermal drug delivery like plasters and biodegradable, subcutaneous implants, Acino supplies the largest Provider on the European pharmaceutical markets. Acino offers the Pharmaceutical industry a comprehensive range of services from the Product development and registration over procurement and contract manufacturing until to packaging and logistics.
The Acino Group is headquartered in Basel, currently operating around 350 Employees and generated annual sales of more than CHF 180 million in Acino Holding AG is listed on the SWX Swiss Exchange (SWX: ACIN).
Data Source: HELP.CH your e-guide ®